This research details the synthesis of biogenic silver nanoparticles utilizing Origanum majorana as a supporting material. The leaves of the plant served as a natural reducing agent and a proficient stabilizer for the generated silver nanoparticles (Ag NPs). The formulated NPs were analyzed through the analysis of their physicochemical properties utilizing UV–Vis, FT-IR, and FE-SEM techniques. The investigation of the antioxidant characteristics of the Ag NPs was followed using the DPPH assay. The results revealed that the silver nanoparticles exhibited considerable antioxidant activity, as evidenced by the IC50 value. Recent findings suggest that the effectiveness of nanoparticles in treating human breast cancer can be linked to their antioxidant characteristics. An evaluation was followed on the ability of biologically synthesized Ag NPs to combat breast cancer in various cell lines. The silver nanoparticles exhibited significant anti-breast cancer properties, successfully eradicating the MCF10 cancer cell line in a manner that was influenced by both time and concentration, as assessed through the MTT assay. Ag NPs facilitate cell apoptosis, a process linked to elevated levels of pro-apoptotic markers, including Bax and cleaved caspase-8, while concurrently reducing the concentration of the anti-apoptotic marker Bcl-2. Furthermore, silver nanoparticles exhibit a decrease in colony formation in comparison to the respective control group. The examination of molecular pathways in cells exposed to Ag NPs revealed a significant elevation in p53 expression, coupled with a decrease in both total and phosphorylated levels of Signal Transducer and Activator of Transcription 3 (STAT3) in the studied cell lines. This suggests that p53 and STAT3 play essential roles in the biological responses triggered by the extract in human breast cancer cells.